Abstract
Mid cut-off (MCO) membrane dialysis is a novel form of haemodialysis (HD) therapy designed to increase clearances of larger middle molecules and uraemic toxins but may result in short-term loss of albumin. REMOVAL-HD study aimed to determine if regular HD using MCO dialyser is safe and specifically will not result in a significant loss of albumin.This study also assessed the efficacy of larger middle molecules clearance and patient-centred outcomes in chronic HD patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
